News
/ News, People
Professor Matthias E. Liechti has been appointed Clinical Professor of Clinical Pharmacology and Toxicology
He will take up his new position on 1 July 2023. Professor Matthias E. Liechti has been appointed Clinical Professor of Clinical Pharmacology and Toxicology at the Faculty of Medicine. This position will begin on 1 July 2023. Liechti has…
/ News, People
Welcome to the team - Mascha Binder Lab!
Prof. Dr. Mascha Binder`s research interests are focused on advancing the field of immunotherapy for solid tumors with a clear translational aim by testing compounds, treatment strategies, and biomarkers inspired by her own preclinical…
/ News, Research
Mechanisms behind aggressive cancer metastases uncovered (Bentires-Alj Lab)
Breast cancer spreading to other organs usually heralds a poorer prognosis. Researchers at the University and University Hospital of Basel have discovered a process that helps breast cancer cells implant themselves in certain places in the…
/ News, Research
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable anti-tumor immunity (Zippelius Lab)
Although immune checkpoint inhibitors (ICIs) have been a breakthrough in clinical oncology, these therapies often fail to produce durable responses in a significant proportion of patients. This lack of long-term efficacy may be attributed…